Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience

被引:4
作者
Pearson, Glen J. [1 ,5 ]
Olson, Kari L. [6 ]
Panich, Nicole E. [1 ]
Majumdar, Sumit R. [2 ,5 ]
Tsuyuki, Ross T. [1 ,4 ]
Gilchrist, Dawna M. [2 ,5 ]
Damani, Ali [4 ]
Francis, Gordon A. [3 ,5 ]
机构
[1] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada
[2] Univ Alberta, Dept Med, Div Gen Internal Med, Edmonton, AB, Canada
[3] Univ Alberta, Dept Med, Div Endocrinol & Metab, Edmonton, AB, Canada
[4] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada
[5] Univ Alberta Hosp, CRRC, Edmonton, AB, Canada
[6] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA
关键词
cardiovascular risk factors; dyslipidemia; outcomes; pharmacotherapy; secondary prevention;
D O I
10.2147/VHRM.S3748
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Specialty cardiovascular risk reduction clinics (CRRC) increase the proportion of patients attaining recommended lipid targets; however, it is not known if the benefits are sustained after discharge. We evaluated the impact of a CRRC on lipid levels and assessed the long-term effect of a CRRC in maintaining improved lipid levels following discharge. Methods: The medical records of consecutive dyslipidemic patients discharged >6 months from a tertiary hospital CRRC from January 1991 to January 2001 were retrospectively reviewed. The primary outcome was the change in patients' lipid levels between the final CRRC visit and the most recent primary care follow-up. A worst-case analysis was conducted to evaluate the potential impact of the patients in whom the follow-up lipid profiles post-discharge from the CRRC were not obtained. Results: Within the CRRC (median follow-up = 1.28 years in 1064 patients), we observed statistically significant improvements in all lipid parameters. In the 411 patients for whom post-discharge lipid profiles were available (median follow-up = 2.41 years), there were no significant differences observed in low-density lipoprotein-cholesterol, total cholesterol (TC), or triglycerides since CRRC discharge; however, there were small improvements in high-density lipoprotein-cholesterol (HDL-C) and TC: HDL ratio (p < 0.05 for both). The unadjusted worst-case analysis (653 patients with no follow-up lipid profiles) demonstrated statistically significant worsening of all lipid parameters between CRRC discharge and the most recent follow-up. However, when the change in lipid parameters between the baseline and the most recent follow-up was assessed in this analysis, the changes in all lipid parameters were significantly improved (p < 0.05). Conclusions: This study demonstrates that a CRRC can improve lipid levels and suggests that these benefits are sustained once patients are returned to the care of their primary physician.
引用
收藏
页码:1127 / 1135
页数:9
相关论文
共 44 条
  • [41] Association between 10-Year Atherosclerotic Cardiovascular Disease Risk and Estimated Glomerular Filtration Rate in Chinese People with Normal to Slightly Reduced Kidney Function: A Cross-Sectional Study
    Chen, Feilong
    Liu, Junting
    Han, Shaomei
    Xu, Tao
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [42] Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study
    Takehiro Funamizu
    Hiroshi Iwata
    Yuya Nishida
    Katsutoshi Miyosawa
    Shinichiro Doi
    Yuichi Chikata
    Jun Shitara
    Hirohisa Endo
    Hideki Wada
    Ryo Naito
    Manabu Ogita
    Tomotaka Dohi
    Takatoshi Kasai
    Shinya Okazaki
    Kikuo Isoda
    Katsumi Miyauchi
    Hiroyuki Daida
    Cardiovascular Diabetology, 19
  • [43] Risk assessment of femoral head AVN following reduction and fixation of intracapsular hip fractures in patients younger than 65 years over a 10 year follow up
    Benady, Amit
    Yehiel, Noy
    Efrima, Ben
    Abdellatif, Adnan
    Vidra, Matias
    Khashan, Morsi
    Ben-Tov, Tomer
    Khoury, Amal
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [44] Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction?: Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL program)
    Hobbs, F. D. Richard
    Gensini, Gianfranco
    Mancini, G. B. John
    Manolis, Athanasios J.
    Bauer, Beverly
    Boehler, Steffen
    Genest, Jacques
    Feldman, Ross
    Harvey, Peter
    Jenssen, Trond G.
    Metcalfe, Michael
    Marques da Silva, Pedro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (02) : 242 - 250